id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-E-1437-0007,FDA,FDA-2013-E-1437,Noice of FInal Determination Letter from U.S. Patent and Trademark Office to CDER,Other,Letter(s),2016-12-28T05:00:00Z,2016,12,2016-12-28T05:00:00Z,,2016-12-28T13:58:12Z,,0,0,090000648243a43d
FDA-2013-E-1437-0006,FDA,FDA-2013-E-1437,Letter from FDA CDER to the U.S. Patent and Trademark Office,Other,Letter(s),2016-08-02T04:00:00Z,2016,8,2016-08-02T04:00:00Z,,2016-08-03T00:50:13Z,,0,0,090000648214fce4
FDA-2013-E-1437-0005,FDA,FDA-2013-E-1437,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2015-12-28T05:00:00Z,2015,12,2015-12-28T05:00:00Z,,2015-12-29T02:25:17Z,,0,0,0900006481dd65b0
FDA-2013-E-1437-0004,FDA,FDA-2013-E-1437,"Determination of Regulatory Review Period for Purposes of Patent Extension: JETREA,",Notice,Determinations,2015-12-23T05:00:00Z,2015,12,2015-12-23T05:00:00Z,2016-02-23T04:59:59Z,2015-12-23T17:26:13Z,2015-32247,0,0,0900006481dcaddd
FDA-2013-E-1437-0003,FDA,FDA-2013-E-1437,Letter from FDA CDER to U.S. Patent and Trademark Office,Other,Letter(s),2014-01-31T05:00:00Z,2014,1,2014-01-31T05:00:00Z,,2014-01-31T16:24:49Z,,0,0,0900006481539888
FDA-2013-E-1437-0001,FDA,FDA-2013-E-1437,U.S. Patent and Trademark Office - Letter,Other,Letter(s),2013-11-15T05:00:00Z,2013,11,2013-11-15T05:00:00Z,,2013-11-15T13:06:03Z,,0,0,090000648147f695
FDA-2013-E-1437-0002,FDA,FDA-2013-E-1437,ThrombGenics NV (Fish & Richardson P.C.) - Patent Term Extension Application,Other,Application,2013-11-15T05:00:00Z,2013,11,2013-11-15T05:00:00Z,,2013-11-15T13:06:03Z,,0,0,090000648147f697